|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Transcriptome Analysis of Arabidopsis Wild-Type and gl3-sst sim Trichomes Identifies Four Additional Genes Required for Trichome Development显示文摘 | M. David Marks Jonathan R Wenger Edward Gilding Ross Jilk Richard A. Dixon | 2009 | Molecular Plant2009，2，4： | 8 |
| 2 | RTP payload format for H.264/SVC scalable video coding显示文摘The scalable extension of H.264/AVC, known as scalable video coding or SVC, is currently the main focus of the Joint Video Team’s work. In its present working draft, the higher level syntax of SVC follows the design principles of H.264/AVC. Self-contained network abstraction layer units (NAL units) form natural entities for packetization. The SVC specification is by no means finalized yet, but nevertheless the work towards an optimized RTP payload format has already started. RFC 3984, the RTP payload specification for H.264/AVC has been taken as a starting point, but it became quickly clear that the scalable features of SVC require adaptation in at least the areas of capability/operation point signaling and documentation of the extended NAL unit header. This paper first gives an overview of the history of scalable video coding, and then reviews the video coding layer (VCL) and NAL of the latest SVC draft specification. Finally, it discusses different aspects of the draft SVC RTP payload format, in- cluding the design criteria, use cases, signaling and payload structure. | WENGER Stephan HANNUKSELA Miska M. | 2006 | Journal of Zhejiang University-Science A(Applied Physics & Engineering)2006，7，5： | 7 |
| 3 | High-resolution multimodal flexible coherent Raman endoscope显示文摘Coherent Raman scattering microscopy is a fast,label-free,and chemically specific imaging technique that shows high potential for future in vivo optical histology.However,the imaging depth in tissues is limited to the sub-millimeter range because of absorption and scattering.Realization of coherent Raman imaging using a fiber endoscope system is a crucial step towards imaging deep inside living tissues and providing information that is inaccessible with current microscopy tools.Until now,the development of coherent Raman endoscopy has been hampered by several issues,mainly related to the fiber delivery of the excitation pulses and signal collection.Here,we present a flexible,compact,coherent Raman,and multimodal nonlinear endoscope(4.2mm outer diameter,71mm rigid length)based on a resonantly scanned hollow-core Kagomé-lattice double-clad fiber.The fiber design enables distortion-less,background-free delivery of femtosecond excitation pulses and back-collection of nonlinear signals through the same fiber.Sub-micrometer spatial resolution over a large field of view is obtained by combination of a miniature objective lens with a silica microsphere lens inserted into the fiber core.We demonstrate high-resolution,high-contrast coherent anti-Stokes Raman scattering,and second harmonic generation endoscopic imaging of biological tissues over a field of view of 320μm at a rate of 0.8 frames per second.These results pave the way for intraoperative label-free imaging applied to real-time histopathology diagnosis and surgery guidance. | Alberto Lombardini Vasyl Mytskaniuk Siddharth Sivankutty Esben Ravn Andresen Xueqin Chen Jérôme Wenger Marc Fabert Nicolas Joly Frédéric Louradour Alexandre Kudlinski Hervé Rigneault | 2018 | Light(Science & Applications)2018，7，1： | 6 |
| 4 | What do the recent American Heart Association/American College of Cardiology Foundation Clinical Practice Guidelines tell us about the evolving management of coronary heart disease in older adults?显示文摘Biological aging predisposes older adults to increased cardiovascular disease (CHD) and greater disease complexity. Given the high age-related prevalence of CHDand age-related compounding factors, the recently updatedAmerican HeartAssociation/American College of Cardiology Foundation CHD-related guidelines increased their focus on older patients. These guidelines are predominately evidence-based (using data from quality randomized clinical trials) and are organized to delineate medications and procedures that best treat particular cardiovascular diseases.While such rationale and thought work well in young and middle aged adults, they become problematic in patientswho are very old. Data pertaining to adults aged ≥80 are virtually absent from most randomized clinical trials, and even in the instances when very old patients were included, eligibility criteria typically excluded candidates with co-morbidities and complexities of customary CHD patients. While medications and interventions yielding benefit in clinical trials should theoretically produce the greatest benefits for patients with high intrinsic risk, age-related cardiovascular complexities also increase iatrogenic risks. Navigating between the potential for high benefit and high risk in “evidence-based”cardiovascular management remains a key Geriatric Cardiology challenge. In this review we consider the expanded Geriatric Cardiology content of current guidelines, acknowledging both the progress that has been made, as well as the work that still needs to be accomplished to truly address the patient-centered priorities of older CHDpatients. | Daniel Forman Nanette K Wenger | 2013 | Journal of Geriatric Cardiology2013，10，2： | 3 |
| 5 | Co-ZrO 2 electrodeposited composite coatings exhibiting improved micro hardness and corrosion behavior in simulating body fluid solution显示文摘 | Lidia Benea Pierre Ponthiaux Francois Wenger | 2011 | Surface & Coatings Technology2011，，： | 2 |
| 6 | Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia显示文摘 | Sarosh Rana Camille E. Powe Saira Salahuddin Stefan Verlohren Frank H. Perschel Richard J. Levine Kee-Hak Lim Julia B. Wenger Ravi Thadhani S. Ananth Karumanchi | 2012 | Circulation2012，，7： | 2 |
| 7 | 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction显示文摘 | Jeffrey L. Anderson Cynthia D. Adams Elliott M. Antman Charles R. Bridges Robert M. Califf Donald E. Casey William E. Chavey Francis M. Fesmire Judith S. Hochman Thomas N. Levin A. Michael Lincoff Eric D. Peterson Pierre Theroux Nanette K. Wenger R. Scott | 2013 | Journal of the American College of Cardiology2013，，23： | 2 |
| 8 | The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years显示文摘有年龄的背景冠的心疾病(CHD ) 风险增加;然而类脂化合物阴沉的治疗是显著地在病人的 under-utilized > 65 年。目的是评估安全,在更老的病人的类脂化合物阴沉的治疗的功效与 atorvastatin 对待 10 mg + ezetimibe 10 mg (EZ/Atorva ) 对增加 atorvastatin 剂量到 40 mg。方法病人有动脉粥样硬化患者的 65 年脉管的疾病(LDL-C 1.81 mmol/L ) 或在为冠的心的高风险,疾病(LDL-C 2.59 mmol/L ) 为 12 wk 对 uptitration 被使随机化到 EZ/Atorva 到为 6 wk 的 20 mg 由 atorvastatin 跟随了的 atorvastatin 为 6 wk 的 40 mg。在完成 prespecified LDL-C 层次的 LDL-C 和另外的类脂化合物参数和百分比病人的百分比变化在 12 wk 以后被估计。结果 EZ/Atorva 在病人在大多数类脂化合物参数对 atorvastatin 的 uptitration 生产了更大的减小 75 年(n = 228 ) ,与病人通常一致 6574 年(n = 812 ) 。更多的病人在 6 wk 并且在病人在两个年龄组与联合治疗对 monotherapy 完成了 LDL-C 目标在 12 wk 的 75 年。在 12 wk,更多的病人 75 年与 monotherapy 对联合治疗完成了 LDL-C 目标。EZ/Atorva 在大多数类脂化合物生产了更有利的改进对加倍或 quadrupling 在病人的 atorvastatin 剂量 75 年,与在病人的调查结果通常一致 6574 年。我们的结果扩大了证明 ezetimibe 增加了 statin 的以前的调查结果的结论为在病人改进类脂化合物侧面提供了一种通常容忍得好的治疗学的选择 65 ~ 74 年和 75 岁。 | Ori Ben-Yehuda Nanette K. Wenger Christian Constance Franklin Zieve Mary E. Hanson Jian-Xin Lin Arvind K. Shah Charlotte Jones-Burton Andrew M. Tershakovec | 2011 | Journal of Geriatric Cardiology2011，8，1： | 2 |
| 9 | Tribocorrosion of stainless steel in sulfuric acid: Identification of corrosion–wear components and effect of contact area显示文摘 | N. Diomidis J.-P. Celis P. Ponthiaux F. Wenger | 2010 | Wear2010，，1： | 2 |
| 10 | Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?显示文摘 | David D Waters John R Guyton David M Herrington Mary P McGowan Nanette K Wenger Charles Shear | 2004 | The American Journal of Cardiology2004，，2： | 2 |
| 11 | The formation, properties and impact of secondary organic aerosol: current and emerging issues显示文摘 | Hallquist M. Wenger J. C. Baltensperger U. Rudich Y. Simpson D. Claeys M. Dommen J. Donahue N. M. George C. Goldstein A. H. Hamilton J. F. Herrmann H. Hoffmann T. Iinuma Y. Jang M. Jenkin M. E. Jimenez J. L. Kiendler-Scharr A. Maenhaut W. McFiggans G. Men | 2009 | Atmospheric Chemistry and Physics2009，，173： | 2 |
| 12 | Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients显示文摘AIM: To study whether the glucocorticoid receptor (GR/ NR3C1) gene haplotypes influence the steroid therapy outcome in inflammatory bowel disease (IBD). METHODS: We sequenced all coding exons and flanking intronic sequences of the NR3C1 gene in 181 IBD patients, determined the single nucleotide polymorphisms, and predicted the NR3C1 haplotypes. Furthermore, we investigated whether certain NR3C1 haplotypes are significantly associated with steroid therapy outcomes. RESULTS: We detected 13 NR3C1 variants, which led to the formation of 17 different haplotypes with a certainty of > 95% in 173 individuals. The three most commonly occurring haplotypes were included in the association analysis of the influence of haplotype on steroid therapy outcome or IBD activity. None of the NR3C1 haplotypes showed statistically signifi cant association with glucocorticoid therapy success. CONCLUSION: NR3C1 haplotypes are not related to steroid therapy outcome. | Jessica Mwinyi Christa Wenger Jyrki J Eloranta Gerd A Kullak-Ublick | 2010 | World Journal of Gastroenterology2010，16，31： | 2 |
| 13 | 实践社团:学习型组织知识管理的新趋势显示文摘1实践社团的定义与构成要素
实践社团(Community of Practice,缩写为CoP)由哈佛大学教授Etienne Wenger在1 998年正式提出,其他译法还包括知识社群、实务社群、实践社群等. | Etienne Wenger 邱昭良 | 2005 | 现代企业教育2005，，7： | 2 |
| 14 | Architecture optimization of a 3-DoF parallel mechanism for machining applications: The orthoglide 显示文摘 | Chablat D Wenger Ph | 2003 | IEEE Transactions on Robotics and Automation2003，19，3： | 1 |
| 15 | Impingement and childhood hip disease显示文摘 | Wenger DR Kishan S Pring ME | 2006 | J Pediatr Orthop2006，15，4： | 1 |
| 16 | The morphology of the residual acetabular deficiency in childhood hipdysplasia:three-dimensional computed tomographic analysis显示文摘 | Kim HT Wenger DR | 1997 | J PediatrOrthop1997，17，： | 1 |
| 17 | Hypoxia-inducible factor-1 alpha regulated at the post-mRNA level显示文摘 | Wenger RH Kvietikova I Rolfs A | 1997 | Kidney Int1997，51，： | 1 |
| 18 | Small bowel enteroscopy and intraoperative enteroscopy for obscure gastrointestinal bleeding显示文摘 | Lewis BS Wenger JS Waye JD | 1991 | AmJ Gastroenterol1991，86，2： | 1 |
| 19 | The influence of pressure on petroleumgeneration and maturation as suggested by squeeze pyrolysis显示文摘 | Price L C Wenger L M | 1992 | Organic Geochemistry1992，19，： | 1 |
| 20 | Autoantibody against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment显示文摘 | Berchtold P Wenger M | 1993 | Blood1993，81，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员